Skip to main content
. 2021 Dec 20;57(1):178. doi: 10.1186/s41983-021-00435-9

Table 3.

Comparisons between both waves regarding the type of neuropathy and outcome

Neuropathy type P
AIDP AMSAN Demyelinating with secondary axonal CIDP like
Wave 1st wave 11 (47.8%) 5 (21.7%) 3 (13.0%) 4 (17.4%) 0.193
2nd wave 14 (73.7%) 3 (15.8%) 2 (10.5%) 0 (0.0%)
Outcome P
Full improvement Minimal improvement No improvement and needed second treatment to improve
Wave 1st wave 14 (60.9%) 3 (13.0%) 6 (26.1%) 0.084
2nd wave 17 (89.5%) 0 (0.0%) 2 (10.5%)

AIDP acute inflammatory demyelinating polyneuropathy, AMSAN acute motor sensory axonal neuropathy, CIDP chronic inflammatory demyelinating polyneuropathy